Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Bispecific anti-VEGF/anti-ANG-2 antibodies and their use in the treatment of ocular vascular diseases

Bispecific anti-VEGF/anti-ANG-2 antibodies and their use in the treatment of ocular vascular diseases

US Patent 10683345 · Granted Jun 16, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of treating cancer by administering tumor necrosis factor (TNF) family l2025
Methods of treating cancer by administering tumor necrosis factor (TNF) family l2025
Use of a cathepsin s inhibitor against the formation of anti-drug antibodies2025
Bispecific antibodies specific for PD1 and TIM32025
Bispecific antibodies specific for PD1 and TIM32025
Bispecific anti-human A-beta/anti-human transferrin receptor antibodies2025
Bispecific anti-human A-beta/anti-human transferrin receptor antibodies2025
Bispecific anti-human A-beta/anti-human transferrin receptor antibodies2025
Methods to determine antibody activity in tumor samples2025
Trispecific antibodies specific for HER2 and a blood brain barrier receptor and 2025
Antigen binding receptors specific for mutated Fc domains2025
Antigen binding receptors specific for mutated Fc domains2025